Animal Life Sciences

Animal Life Sciences

Early Stage

Human health engineered for pets

Human health engineered for pets

Overview

Raised to Date: Raised: $0

Total Commitments ($USD)

Platform

Republic

Start Date

05/12/2020

Close Date

10/17/2020

Min. Goal
$100,000
Max. Goal
$1,070,000
Min. Investment

$250

Security Type

Equity - Common

Series

Seed

SEC Filing Type

RegCF    Open SEC Filing

Price Per Share

$1.00

Pre-Money Valuation

$6,500,000

Rolling Commitments ($USD)

Status
Not Funded
Reporting Date

10/17/2020

Days Remaining
Not Funded
% of Min. Goal
Not Funded
% of Max. Goal
Not Funded
Likelihood of Max
Not Funded
Avg. Daily Raise

$0

Momentum
Not Funded
Create a free account today to gain access to KingsCrowd analytics.
Year Founded

2018

Industry

Pet Health, Food, and Services

Tech Sector

HealthTech

Distribution Model

B2B

Margin

High

Capital Intensity

High

Location

Houston, Texas

Business Type

Growth

Animal Life Sciences, with a valuation cap of $6.5 million, is raising funds on Republic. It is an innovative pharmaceutical development company applying human health innovations to veterinary medicine. The company licenses, develops, and commercializes safe and effective treatments from some of the deadly diseases in cats and dogs. Animal Life Sciences was founded by Dr. Waldemar Priebe in August 2018. The proceeds of the current crowdfunding campaign, with a minimum goal of $100,000 and a maximum goal of $1,070,000, will be used to continue the development of technologies and its proprietary line of healthy pet food and supplements. Animal Life Sciences has already licensed ten patent-pending medications and plans to launch its products through e-commerce in late 2020.

Summary Profit and Loss Statement

Most Recent Year Prior Year

Revenue

$0

$0

COGS

$0

$0

Tax

$0

$0

 

 

Net Income

$-96,475

$-1,599

Summary Balance Sheet

Most Recent Year Prior Year

Cash

$109,067

$16,692

Accounts Receivable

$0

$0

Total Assets

$149,568

$36,947

Short-Term Debt

$4,077

$46

Long-Term Debt

$0

$26,000

Total Liabilities

$4,077

$26,046

Financials as of: 05/12/2020
Create a free account today to gain access to KingsCrowd analytics.

Funding data not publicly available

Upgrade to gain access

Pay Monthly
Annually (Save 17%)

Edge

$25 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific KingsCrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Ratings KingsCrowd Startup Rating Methodology Article

Blurred Ratings Bars Blurred Ratings Bars
Founders: enhance your startup's credibility on KingsCrowd. Create an account to claim this raise page.

Create your first portfolio

Create your own startup investment portfolio on KingsCrowd.

Track all of your startup investments in one place using our state-of-the-art portfolio tracker tools. To begin, create your first portfolio below.

Add to portfolio
Animal Life Sciences on Republic
Platform: Republic
Security Type: Equity - Common
Valuation: $6,500,000
Price per Share: $1.00

Follow company

Follow Animal Life Sciences on Republic

Buy Animal Life Sciences's Deal Report

Warning: according to the close date for this deal, Animal Life Sciences may no longer be accepting investments.

Animal Life Sciences Deal Report

Get KingsCrowd’s comprehensive report on Animal Life Sciences including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Animal Life Sciences is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Animal Life Sciences deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge